{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:56:10Z","timestamp":1787320570925,"version":"build-2736575974"},"reference-count":21,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/03007995.2025.2607542","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:09:36Z","timestamp":1769760576000},"page":"2323-2338","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Patient-reported outcomes among patients with mantle cell lymphoma or chronic lymphocytic leukemia receiving pirtobrutinib in the BRUIN phase 1\/2 study: final analysis"],"prefix":"10.1080","volume":"41","author":[{"given":"Catherine C.","family":"Coombs","sequence":"first","affiliation":[{"name":"University of California Irvine","place":["Irvine, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Woyach","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute and Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[{"name":"Universita Vita-Salute San Raffaele Milano","place":["Milano, Italy"]},{"name":"IRCCS Ospedale San Raffaele","place":["Milano, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey E.","family":"Roeker","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish","family":"Patel","sequence":"additional","affiliation":[{"name":"Swedish Cancer Institute","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby A.","family":"Eyre","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center","place":["Oxford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine S.","family":"Tam","sequence":"additional","affiliation":[{"name":"Alfred Hospital and Monash University","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[{"name":"Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav N.","family":"Shah","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin","place":["Milwaukee, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Flinn","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute\/Tennessee Oncology\/OneOncology","place":["Nashville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Y.","family":"Cheah","sequence":"additional","affiliation":[{"name":"Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia","place":["Perth, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Ma","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute","place":["New Brunswick, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Jurczak","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie National Research Institute of Oncology","place":["Krakow, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Wierda","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3631-3941","authenticated-orcid":false,"given":"Lisa M.","family":"Hess","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company","place":["Indianapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naleen Raj","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company","place":["Indianapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angely","family":"Loubert","sequence":"additional","affiliation":[{"name":"Modus Outcomes","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo B.","family":"Abada","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company","place":["Indianapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lamanna","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center, Columbia University","place":["New Year, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285754"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00562"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-01700"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000971344.34270.c5"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2025.04.1411"},{"key":"e_1_3_4_7_1","first-page":"e219","article-title":"Patient-reported outcomes from BRUIN CLL\u2010321: phase 3 trial comparing pirtobrutinib to idelalisib\/rituximab or bendamustine\/rituximab in covalent BTKi pretreated CLL\/SLL","volume":"43","author":"Ghia P","year":"2025","unstructured":"Ghia P, Rossi D, Ferrant E, et al. Patient-reported outcomes from BRUIN CLL\u2010321: phase 3 trial comparing pirtobrutinib to idelalisib\/rituximab or bendamustine\/rituximab in covalent BTKi pretreated CLL\/SLL. Hematol Oncol. 2025;43:e219.","journal-title":"Hematol Oncol"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.03.188"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-024-00683-2"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.139"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.02.059"},{"key":"e_1_3_4_13_1","article-title":"Psychometric analysis of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library","author":"Loubert A","year":"2025","unstructured":"Loubert A, Creel K, Bhandari NR, et al. Psychometric analysis of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library. J Patient Rep Outcomes. 2025; Submitted.","journal-title":"J Patient Rep Outcomes"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70094_219"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022353"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0976"},{"key":"e_1_3_4_17_1","unstructured":"SEER. The surveillance epidemiology and end results (SEER) program of the National Cancer Institute Cancer Statistics; 2025."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70011"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep16010006"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.14425"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-020-00231-w"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2262378"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2025.2607542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:56:58Z","timestamp":1772708218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2025.2607542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/03007995.2025.2607542"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2025.2607542","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}